Abnormalities in the p53 gene in tumors and cell lines of human squamous‐cell carcinomas of the head and neck

International Journal of Cancer

Volumn 54, Issue 2, 1993, Pages 322-327

  Yin, Xiao‐Ying ^a,b   Smith, Martin L ^a   Whiteside, Theresa L ^a,b   Locker, Joseph ^a,b   Johnson, Jonas T ^a   Herberman, Ronald B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ALLELES; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027315554     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910540226     Document Type: Article

References (32)

1. Suppression of human colorectal carcinoma cell growth by wild‐type p53
2. The new oncogene encodes an epidermal‐growth‐factor‐receptor‐related protein
3. Epidemiology of squamous‐cell carcinoma of the head and neck
4. Frequent mutations in the p53 tumor‐suppressor gene in human leukemia T‐cell lines
5. Oncogene amplification in breast cancer
6. A technique for radiolabeling DNA‐restriction‐endonuclease fragments to high specific activity
7. Elevated p53 expression correlates with a history of heavy smoking in squamous‐cell carcinoma of the head and neck
8. Activating mutations for transformation by p53 produce a gene product that forms an hsc‐70‐p53 complex with an altered half‐life
9. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma
10. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
11. Expression of p53 in pre‐malignant and malignant squamous epithelium
12. Monoclonal antibodies specific for simian virus 40 tumor antigens
13. Biology, cytogenetics, and sensitivity to immunological effector cells of new head‐and‐neck squamous‐cell carcinoma lines
14. Frequent mutation of the p53 gene in human esophageal cancer
15. Mitotic recombination of chromosome 17 in astrocytomas
16. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines
17. A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single‐copy probe p144‐D6 (HGM9 No. D17534)
18. Variable methylation of the ribosomal RNA genes of the rat
19. p53: Oncogene or anti‐oncogene?
20. Isolation and characterization of human myosin heavy‐chain genes
21. Tumor‐suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products
22. The p53 tumor‐suppressor gene
23. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
24. Rearrangement of the p53 gene in human osteogenic sarcomas
25. Inactivation of the cellular p53 gene is a common feature of friend‐virus‐induced erythro‐leukemia: relationship of inactivation to dominant transforming alleles
26. Mutations in the p53 gene occur in diverse human tumor types
27. A human retinoic acid receptor which belongs to the family of nuclear receptors
28. Evidence that p53 behaves as a tumor‐suppressor gene in sporadic breast tumors
29. p53 mutations in colorectal cancer
30. Expression of p53 mutant protein(s) in dimethylnitrosamine‐induced foci of enzyme‐altered hepatocytes in male Fischer‐344 rats
31. Gene amplification and gene dosage in cell lines derived from squamous‐cell carcinoma of the head and neck
32. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells